Crescendo Bioscience Lands $31,019,775 Series C Financing
341 Oyster Point Blvd South San Francisco, CA 94080
Crescendo Bioscience is developing a broad range of quantitative, objective diagnostic tools to provide Rheumatologists with deeper clinical insights to more effectively manage patients with autoimmune and inflammatory diseases.
Proceeds purposes were not disclosed. SEC regulatory filing.
Trending on Xconomy
[toplytics period="week" numberposts="3"]